DRKS00023398招募中不适用
Predicting the impact of the gut microbiome on immunosuppressive drug metabolism in kidney transplant patients - PRISMA
niversitätsklinikum Heidelberg0 个研究点目标入组 130 人开始时间: 2020年10月26日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 130
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- one 至 one（—）
- 性别
- All
入选标准
- •(i) Recipients of a living kidney donor transplant of any age or
- •patients on the waiting list for deceased kidney donor transplantation of any age
- •(ii) Treatment with tacrolimus as part of their immunosuppressive regimen during at least two time periods within the study period
- •(iii) Written informed consent from adult patients, who are able to give consent
- •(iv) Patient consent and written informed consent from caregivers from underage patient
排除标准
- •(i) Patients with preexisting liver disease defined as cirrhosis, systemic inflammation (infectious, chemical or autoimmune) or hepatic tumors
- •(ii) Non- Caucasian patients
研究者
相似试验
已完成
1 期
Assessment of the influence of the gut microbiome on tacrolimus pharmacokinetics in healthy volunteersPharmacokinetic trial in healthy volunteersDRKS00032072niversitätsklinikum Heidelberg, Im Wege der Auftragsverwaltung für die Universität Heidelberg, Medizinische Fakultät Heidelberg20
招募中
3 期
Targeting the gut microbiome as a treatment for Primary Sclerosing Cholangitis: The Queensland Clinical Network StudyPrimary Sclerosing CholangitisACTRN12621000792820Princess Alexandra Hospital34
暂停
不适用
Influence of the intestinal microbiome on the risk of spontaneous bacterial peritonitis in patients with decompensated liver cirrhosisK65K74.6Other and unspecified cirrhosis of liverPeritonitisDRKS00026834Klinik und Poliklinik für Innere Medizin II Klinikum rechts der Isar der TU München120
已完成
不适用
The analysis of influences on the gut microbiota, the glycometabolism and the peritoneal permeability by the induction of dialysis and the peritonitis prevalence in peritoneal dialysis patients.end stage renal failureJPRN-UMIN000014814Keio university school of medicine20
已完成
不适用
The intestinal microbiome as a predictive biomarker for efficacy and side effects of CAR-T cell therapy in blood cancersC91.0C83.3Acute lymphoblastic leukaemia [ALL]Diffuse large B-cell lymphomaDRKS00020506Deutsches Krebsforschungszentrum (DKFZ)66